Lai Li, Yue Xuan
Operating Room, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, China.
Department of Urology, West China Hospital, Sichuan University, Chengdu, China.
Front Pediatr. 2021 May 31;9:632308. doi: 10.3389/fped.2021.632308. eCollection 2021.
Multiple Randomized controlled trials (RCTs) have evaluated the efficacy of antimicrobial-impregnated catheters to prevent catheter-related bloodstream infections (CRBSI). However, the RCTs showed contradictory results, the studies were limited in sample size and methodology quality. Thus, we conducted a meta-analysis to overcome these RCT limitations. We designed a meta-analysis of RCTs comparing antimicrobial-impregnated and conventional catheters for the prevention of CRBSI. We conducted a detailed search of various databases for RCTs published before November 2019. We calculated mean differences (MDs) and pooled odds ratios (ORs) with 95% confidence intervals (CIs) using a random-effects model. We included five RCTs with a total of 2,294 patients. The incidence of CRBSI between the two groups was 0.50 (95% CI, 0.19-1.27), with evidence of heterogeneity ( = 55%). The difference was not statistically significant ( = 0.15). On subgroup analysis based on the age of the sample, there was no difference in the rate of CRBSI in the neonatal population [0.42 (95% CI, 0.08-2.27 = 61% = 0.31] as well as pediatric population [0.45 (95% CI, 0.12-1.67 = 39% = 0.23]. The summary OR on the incidence of catheter colonization between antimicrobial-impregnated and conventional catheters was 0.64 (95% CI, 0.17-2.35), with no evidence of heterogeneity ( = 0%) and a non-significant difference ( = 0.50). To conclude, analysis of a limited number of heterogeneous studies mostly with a small sample indicates that the CRBSI and catheter colonization rates are similar between conventional and antimicrobial-impregnated catheters in the pediatric and neonatal population. There is an urgent need for large-scale RCTs focusing on different antimicrobial-impregnated catheters in these patients to further enhance current evidence.
多项随机对照试验(RCT)评估了抗菌导管预防导管相关血流感染(CRBSI)的疗效。然而,这些RCT结果相互矛盾,研究在样本量和方法学质量方面存在局限性。因此,我们进行了一项荟萃分析以克服这些RCT的局限性。我们设计了一项RCT的荟萃分析,比较抗菌导管和传统导管预防CRBSI的效果。我们对各种数据库进行了详细检索,以查找2019年11月之前发表的RCT。我们使用随机效应模型计算了平均差(MD)和合并比值比(OR)以及95%置信区间(CI)。我们纳入了5项RCT,共2294例患者。两组之间CRBSI的发生率为0.50(95%CI,0.19 - 1.27),存在异质性证据(I² = 55%)。差异无统计学意义(P = 0.15)。基于样本年龄的亚组分析显示,新生儿人群中CRBSI发生率无差异[0.42(95%CI,0.08 - 2.27),I² = 61%,P = 0.31],儿科人群中也无差异[0.45(95%CI,0.12 - 1.67),I² = 39%,P = 0.23]。抗菌导管和传统导管之间导管定植发生率的汇总OR为0.64(95%CI,0.17 - 2.35),无异质性证据(I² = 0%)且差异无统计学意义(P = 0.50)。总之,对数量有限、大多样本量较小的异质性研究进行分析表明,在儿科和新生儿人群中,传统导管和抗菌导管的CRBSI及导管定植率相似。迫切需要针对这些患者开展聚焦于不同抗菌导管的大规模RCT,以进一步完善现有证据。